Clinical Trial: Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Hypertriglyceridemia
Study Type: INTERVENTIONAL
Official Title: Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults With Hypertriglyceridemia
Brief Summary:
This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia (HTG). After providing informed consent eligible participants will be randomized to receive 4 doses (once every 3 months) of plozasiran or placebo and be evaluated for efficacy and safety.
Read more